scispace - formally typeset
S

Sean P. Colgan

Researcher at Anschutz Medical Campus

Publications -  323
Citations -  31494

Sean P. Colgan is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Inflammation & Intestinal mucosa. The author has an hindex of 89, co-authored 301 publications receiving 27723 citations. Previous affiliations of Sean P. Colgan include Veterans Health Administration & Harvard University.

Papers
More filters
Journal ArticleDOI

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

TL;DR: It is reported that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid produce a novel family of bioactive 17R-hydroxy-containing di- and tri-Hydroxy-docosanoids termed resolvins.
Journal ArticleDOI

Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

TL;DR: It is reported that inflammatory exudates from mice treated with ω-3 polyunsaturated fatty acid and aspirin (ASA) generate a novel array of bioactive lipid signals, which provides a novel mechanism for the therapeutic benefits ofπ-3 dietary supplementation, which may be important in inflammation, neoplasia, and vascular diseases.
Journal Article

Hypoxia-inducible Factor-1-dependent Regulation of the Multidrug Resistance (MDR1) Gene

TL;DR: Hypoxia-elicited MDR1 gene induction and increased P-glycoprotein expression in nontransformed, primary cultures of human microvascular endothelial cells, and analysis of multicellular spheroids subjected to hypoxia revealed increased resistance to doxorubicin are confirmed.